Literature DB >> 8374845

Report of the Canadian Hypertension Society Consensus Conference: 5. Hypertension and diabetes.

K G Dawson1, J K McKenzie, S A Ross, J L Chiasson, P Hamet.   

Abstract

Entities:  

Mesh：

Year:  1993        PMID： 8374845      PMCID： PMC1485364     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  77 in total

Review 1.  Recommendations from the Canadian Hypertension Society Consensus Conference on Hypertension and Diabetes.

Authors:  P Hamet; N Kalant; S A Ross; T W Wilson; F H Leenen; R B Haynes
Journal:  CMAJ       Date:  1988-12-01       Impact factor: 8.262

2.  Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy.

Authors:  E R Seaquist; F C Goetz; S Rich; J Barbosa
Journal:  N Engl J Med       Date:  1989-05-04       Impact factor: 91.245

3.  Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man.

Authors:  J W Rowe; J B Young; K L Minaker; A L Stevens; J Pallotta; L Landsberg
Journal:  Diabetes       Date:  1981-03       Impact factor: 9.461

4.  Eight-month correction of hyperglycemia in insulin-dependent diabetes mellitus is associated with a significant and sustained reduction of urinary albumin excretion rates in patients with microalbuminuria.

Authors:  J J Bending; G C Viberti; R W Bilous; H Keen
Journal:  Diabetes       Date:  1985-08       Impact factor: 9.461

5.  Regression of microalbuminuria in type II diabetic, hypertensive patients after long-term indapamide treatment.

Authors:  S Gambardella; S Frontoni; A Lala; M G Felici; V Spallone; A Scoppola; F Jacoangeli; G Menzinger
Journal:  Am Heart J       Date:  1991-10       Impact factor: 4.749

6.  Comparative effects of converting enzyme inhibition and conventional therapy in hypertensive non-insulin dependent diabetics with normal renal function.

Authors:  Y Lacourcière; A Nadeau; L Poirier; G Tancrède
Journal:  Clin Invest Med       Date:  1991-12       Impact factor: 0.825

7.  Antihypertensive therapy with Ca2+. Antagonist verapamil and/or ACE inhibitor enalapril in NIDDM patients.

Authors:  C Ferrier; P Ferrari; P Weidmann; U Keller; C Beretta-Piccoli; W F Riesen
Journal:  Diabetes Care       Date:  1991-10       Impact factor: 19.112

Review 8.  Vascular smooth muscle cell proliferation and its therapeutic modulation in hypertension.

Authors:  V Hadrava; U Kruppa; R C Russo; Y Lacourcière; J Tremblay; P Hamet
Journal:  Am Heart J       Date:  1991-10       Impact factor: 4.749

9.  Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study.

Authors:  J H Fuller; M J Shipley; G Rose; R J Jarrett; H Keen
Journal:  Lancet       Date:  1980-06-28       Impact factor: 79.321

Review 10.  Epidemiology of hypertension in diabetic patients and implications for treatment.

Authors:  J H Fuller; L K Stevens
Journal:  Diabetes Care       Date:  1991-11       Impact factor: 19.112
View more
  10 in total

1.  Contemporary practice patterns in the management of newly diagnosed hypertension.

Authors:  F A McAlister; K K Teo; R Z Lewanczuk; G Wells; T J Montague
Journal:  CMAJ       Date:  1997-07-01       Impact factor: 8.262

Review 2.  Cost-effective therapy for hypertension.

Authors:  W Barrie
Journal:  West J Med       Date:  1996-04

Review 3.  [Hypertension. A new way to approach an old problem].

Authors:  M Aubin
Journal:  Can Fam Physician       Date:  1996-04       Impact factor: 3.275

4.  Hypertension in pregnancy: new recommendations for management.

Authors:  P Hamet
Journal:  CMAJ       Date:  1997-09-15       Impact factor: 8.262

Review 5.  A model of long-term metabolic progression of type 2 diabetes mellitus for evaluating treatment strategies.

Authors:  Adrian Bagust; Marc Evans; Sophie Beale; Philip D Home; Andrew S Perry; Murray Stewart
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

6.  Clinical problem solving based on the 1999 Canadian recommendations for the management of hypertension.

Authors:  R D Feldman; N R Campbell; P Larochelle
Journal:  CMAJ       Date:  1999       Impact factor: 8.262

7.  1999 Canadian recommendations for the management of hypertension. Task Force for the Development of the 1999 Canadian Recommendations for the Management of Hypertension.

Authors:  R D Feldman; N Campbell; P Larochelle; P Bolli; E D Burgess; S G Carruthers; J S Floras; R B Haynes; G Honos; F H Leenen; L A Leiter; A G Logan; M G Myers; J D Spence; K B Zarnke
Journal:  CMAJ       Date:  1999       Impact factor: 8.262

8.  Treating hypertension. Are the right drugs given to the right patients?

Authors:  M D Beaulieu; L Dufresne; D LeBlanc
Journal:  Can Fam Physician       Date:  1998-02       Impact factor: 3.275

Review 9.  [Diabetic nephropathy].

Authors:  D Garceau; M Turgeon; S Gagnon
Journal:  Can Fam Physician       Date:  1995-05       Impact factor: 3.275

Review 10.  Canadian Hypertension Education Program: the evolution of hypertension management guidelines in Canada.

Authors:  Ross D Feldman; Norman R C Campbell; Katherine Wyard
Journal:  Can J Cardiol       Date:  2008-06       Impact factor: 5.223
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.